DexCom Overview

  • Founded
  • 1999
Founded
  • Status
  • Public
  • Employees
  • 6,400
Employees
  • Stock Symbol
  • DXCM
Stock Symbol
  • Investments
  • 5
  • Share Price
  • $566.57
  • (As of Friday Closing)

DexCom General Information

Description

Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.

Contact Information

Website
www.dexcom.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Monitoring Equipment
Stock Exchange
NAS
Primary Office
  • 6340 Sequence Drive
  • San Diego, CA 92121
  • United States
+1 (855) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DexCom Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$566.57 $568.10 $305.63 - $579.00 $55B 96.7M 561K $5.57

DexCom Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 40,533,308 34,718,025 19,701,763 10,320,953
Revenue 2,169,900 1,926,700 1,476,000 1,031,600
EBITDA 427,700 360,700 186,800 (77,100)
Net Income 530,600 493,600 101,100 (127,100)
Total Assets 4,503,800 4,290,500 2,395,000 1,916,000
Total Debt 1,894,000 1,839,500 1,160,100 1,017,600
Public Fundamental Data provided by Morningstar, Inc. disclaimer

DexCom Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore DexCom‘s full profile, request access.

Request a free trial

DexCom Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore DexCom‘s full profile, request access.

Request a free trial

DexCom Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternati
Monitoring Equipment
San Diego, CA
6,400 As of 2020
00000
000000000 00000

00000000

eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia
0000000000 000000000
Germantown, MD
00 As of 0000
00000
00000000000 00000

00000000

velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, s
0000000000 000000000
Malvern, PA
0000 As of 0000
00.000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DexCom Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Senseonics Formerly VC-backed Germantown, MD 00 00000 00000000000 00000
00000000 Private Equity-Backed Malvern, PA 0000 00.000 000000000 00.000
000000000 Formerly Accelerator/Incubator backed London, United Kingdom 00 000000&0
000000000 00000000 Corporation Ashdod, Israel 00 000.00 000000000 000.00
000000000 Venture Capital-Backed Salem, NH 000 00000 00000000000 00000
You’re viewing 5 of 11 competitors. Get the full list »

DexCom Patents

DexCom Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210290119-A1 Analyte sensor Pending 07-Jun-2021 00000000000
US-20210282682-A1 Analyte sensor Pending 28-May-2021 000000000
US-20210290163-A1 Invasive biosensor alignment and retention Pending 02-Feb-2021 0000000000
US-20210267506-A1 Evaluation of data to provide decision support for a ketogenic lifestyle Pending 02-Mar-2020 00000000000
US-20210260286-A1 Machine learning in an artificial pancreas Pending 20-Feb-2020 A61B5/14532

DexCom Executive Team (39)

Name Title Board Seat Contact Info
Kevin Sayer Chief Executive Officer, Executive Chairman & President
Jereme Sylvain Executive Vice President and Chief Financial Officer
Jake Leach Chief Technology Officer, Technology & Executive Vice President
Steven Pacelli JD General Manager
Patrick Murphy JD Executive Vice President , Chief Legal & Compliance Officer and General Counsel
You’re viewing 5 of 39 executive team members. Get the full list »

DexCom Board Members (13)

Name Representing Role Since
Barbara Kahn Self Board Member 000 0000
Bridgette Heller DexCom Board Member 000 0000
Eric Topol MD Self Board Member 000 0000
Jay Skyler MD Self Board Member 000 0000
Karen Dahut Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

DexCom Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DexCom Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 0000000 000000 01-Aug-2021 000000000000000000 Diagnostic Equipment
0000 0000000 09-Jan-2019 00000 00000 00 0000 Monitoring Equipment
00000000 22-Aug-2018 000000000000000000 000.00 Other Healthcare Technology Systems 00000 00000
00000000 02-May-2016 000000000000000000 00.00 Medical Supplies 00000 00000
SweetSpot Diabetes Care 06-Mar-2012 Merger/Acquisition 00.00 Enterprise Systems (Healthcare) 00000000 00000
To view DexCom’s complete investments and acquisitions history, request access »

DexCom Subsidiaries (2)

Company Name Industry Location Founded
TypeZero Other Healthcare Technology Systems Charlottesville, VA 2013
000 0000000 000000 Diagnostic Equipment Auckland, New Zealand 0000
To view DexCom’s complete subsidiaries history, request access »